BME100 f2014:Group10 L2

Jump to navigationJump to search
BME 100 Fall 2014 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help

OUR TEAM

 Name: Meredith Bothman Name: Dawei Jiang Name: Cera Lange Name: Steven Nguyen Name: Brett Pinar Name: Eun Duk Seo

LAB 2 WRITE-UP

Descriptive Statistics

Human Study

• Mean amount of inflammotin produced
 Dosage 0 mg 5 mg 10 mg 15 mg Mean 3.834 mg 8.932 mg 61.622 mg 657.941 mg
• Variability within test groups
 Dosage 0 mg 5 mg 10 mg 15 mg Standard Deviation 1.523 1.594 30.111 212.943 Standard Error 0.482 0.504 9.522 67.338

Rodent Study

• Mean amount of inflammotin produced
 Dosage 0 mg 10 mg Mean 10.516 mg 11.112 mg
• Variability within test groups
 Dosage 0 mg 10 mg Standard Deviation 2.226 7.403 Standard Error 0.995 3.311

Results

Human Study

• bars denote significance

Rodent Study

Analysis

Human Study

• A one-way ANOVA was used to determine significance since the data is single-factor and has several groups.
• ANOVA results; p-value: 1.4 x 10^-16
• Based on the p-value from our ANOVA test, we can determine that the difference in the results is significant since the p-value was small
• Bonferroni Correction

To be statistically significant, the p-value must be less than 0.00833

 Post-Hoc Tests P-value Significant? 0 mg vs. 5 mg 8.59631E-07 yes 0 mg vs. 10 mg 9.94377E-06 yes 0 mg vs. 15 mg 1.39436E-08 yes 5 mg vs. 10 mg 3.01859E-05 yes 5 mg vs. 15 mg 1.57101E-08 yes 10 mg vs. 15 mg 6.4824E-08 yes

This shows that a statistically significant difference exists between all dosages.

Rodent Study

• A t-test was used to determine significance since the data is single-factor and has more than two groups.
• t-test result: .8674035
• Based on our result from the t-test, we can determine that the difference in results is not significant.

Summary/Discussion

The data showed that increased dosages of LPS increased inflammotin in humans in exponentially increasing increments based on dosage. Lipopolysaccharide had no effect during the rodent trials. This data shows that a greater amount of dosages should have been tested on rats. The lack of responsiveness from the rats could have been taken as a sign of the ineffectiveness of the drug, and its benefits to humans could have been overlooked. This data shows that different medications and treatments can have different effects on different organisms, so in vitro testing is extremely important to ensure that medications that can treat humans are not dismissed because of their lack of effectiveness in rodent studies.